The Philippines will likely start by end of this month or early November its “Mix and Match” trial or MnM study to determine the safety and immunogenicity of mixing different coronavirus disease (COVID-19) vaccines and vaccine platforms in Filipino adults. (MANILA BULLETIN FILE PHOTO) DOST...
The recruitment of participants for the World Health Organization’s (WHO) Solidarity Vaccines Trial (SVT) has been piloted in three hospitals in Metro Manila, the Department of Science and Technology (DOST) said. (MANILA BULLETIN FILE PHOTO) DOST Undersecretary for Research and Development...
The Philippines has conducted clinical studies to determine the efficacy of virgin coconut oil (VCO) as adjunct treatment against coronavirus disease (COVID-19). (MANILA BULLETIN FILE PHOTO ) Department of Science and Technology (DOST) Undersecretary for Research and Development (R&D) Dr....
The foreign vaccine developers that will be assisting local pharmaceutical companies in setting up a “fill and finish” facility for coronavirus disease (COVID-19) vaccines may be known soon, the Department of Science and Technology (DOST) said Saturday, Oct. 23. (UNSPLASH/MANILA BULLETIN FILE)...
The country’s clinical trials on the use of virgin coconut oil (VCO), lagundi (Chinese chaste tree) and tawa-tawa (Euphorbia hirta) as adjunct therapy, herbal medicine, and adjunctive treatment against coronavirus disease (COVID-19) may benefit the country’s farmers, the Department of Science...
The Department of Science and Technology (DOST) said Saturday, Oct. 23, said the recruitment of over 1,400 participants for the eight month-long clinical Ivermectin clinical trials is expected to start in November, and that the initial results of the study may be out by end of December this year....
The Philippines’ study on the safety and immunogenicity of mixing different coronavirus disease (COVID-19) vaccines and vaccine platforms in Filipino adults may start soon. (MANILA BULLETIN FILE PHOTO) During his weekly report on Friday, Oct. 22, Department of Science and Technology (DOST)...
Tawa-tawa (Euphorbia hirta) extract is proving to be an effective adjunctive coronavirus disease (COVID-19) treatment for mild to moderate cases, the Department of Science and Technology (DOST) disclosed. Tawa-tawa (MANILA BULLETIN FILE PHOTO) DOST Undersecretary for Research and Development...
Using lagundi as herbal medicine for mild coronavirus disease (COVID-19) patients yielded positive results, the Department of Science and Technology (DOST) said. Lagundi (MANILA BULLETIN FILE PHOTO) DOST Undersecretary for Research and Development (R&D) Rowena Cristina Guevara bared the initial...
The Department of Science and Technology (DOST) said Sunday, Oct. 17, that the results of the virgin coconut oil (VCO) trial at Philippine General Hospital (PGH) which aims to determine the safety and efficacy of VCO as adjunctive therapy for coronavirus disease (COVID-19) cases may be out by end...
The Philippines will produce its own Ivermectin capsule, the Department of Science and Technology (DOST) said Sunday, Oct. 17. (MANILA BULLETIN FILE PHOTO) DOST Undersecretary for Research and Development (R&D) Rowena Cristina Guevara said the University of the Philippines (UP) Manila College...
The second and third phases of the clinical study on the safety and efficacy of the plant-based anti-dengue drug will start in September this year, and "will be completed within a year", the Department of Science and Technology (DOST) said on Friday, Aug. 20. (MANILA BULLETIN FILE PHOTO) DOST...
